US COVID-19 Advisors Vexed By Vaccine Post-EUA Placebo Controls, But Agree On Need

 
• By Sarah Karlin-Smith

FDA indicates it expects sponsors and other government agencies to come up with ways to fulfill its request for placebo-controlled studies post-emergency use authorization of COVID-19 vaccines, but neither it nor vaccines advisory committee see a clear way to do this. 

No U turn sign (source: Shutterstock)
Sponsors need to push ahead with placebo-controlled COVID-19 vaccine studies post-EUA, agency advisors say. • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers